The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Homeland Security color-coded Advisory System

Somewhere North of the Rainbow

I’ve got my own personal Homeland Security color-coded Advisory System. It goes like this:

Green: Doesn’t register
Blue: Doesn’t register
Yellow: Doesn’t register
Orange: TV news reporting quickly becomes annoying
Red: Now you’ve got my attention

Let’s face it; the Green and Blue levels are the refreshing cool color levels to which it seems we may never return. Yellow is where we mostly live these days. We pop up to Orange every now and then, which is where parts of New York City, northern New Jersey, and Washington, D.C., are right now. And Red well, we’ll cross the Red bridge when we get to it (and hopefully never will).

At least one regulatory agency has found a way to put the Advisory System to use. Earlier this month, just a few days after the Department of Homeland Security raised the threat level to Orange for the areas mentioned above, Food and Drug Administration Commissioner Lester M. Crawford sat down with The Associated Press to discuss “cues” that had been picked up “from chatter.”

And guess what? It turns out that one potential terrorist target just happens to be an FDA target too!

Bow wow

For many months (or is it years now?), the FDA has been discouraging U.S. citizens from buying their prescription drugs at a lower cost from Canada. This is a sticky political wicket, because most of those who are purchasing the lower-priced drugs tend to be seniors who unfortunately have been led to believe they can’t live without their expensive cholesterol-lowering statin drugs and any number of other prescriptions.

Naturally, no current office holders want to anger this huge block of seniors and lose their votes by strictly enforcing the laws against buying drugs from foreign sources. So the government’s attempts to stop these sales have consisted of mostly barking, with not much bite.

For instance, one of the FDA’s tactics is to send out warning letters to the governors of northern states. Ouch! A LETTER from the FDA. That’s gotta hurt!

The letters are designed to warn about the questionable safety and effectiveness of illegally imported drugs. But the fact that Canadians don’t seem to have a problem with safety and effectiveness of their drugs sort of takes the bite out of those scary letters. Especially because it’s widely known that many of the imported drugs come from the very offshore factories that produce drugs sold in the U.S.

Planting seeds

Then Commissioner Crawford came up with what probably seemed like a good way to make those “questionable” drugs really scary.

He told The Associated Press that he had been briefed about al- Qaida threats that were uncovered by the recent raids in Pakistan and the UK. When he was asked if the briefing revealed terrorist plans to contaminate food or drugs, Crawford said that he would have to decline comment.

Very ominous.

So while he didn’t come right out and say it, the point was implied: If you use these illegally imported drugs you may make yourself vulnerable to terrorists. But then in the same article, a spokesman for Homeland Security admits that there is no specific information about any al-Qaida threats to food or drugs.

Bark, bark, bark. No bite.

The lemon caper

Commissioner Crawford tried to sharpen the edge on the terrorist fear by pointing to the Tylenol tampering in 1982 that led to seven deaths. He had to go back more than two decades for that one! And the drugs in question were obviously not imported.

But that’s not all. A few bottles of baby food were recently contaminated in California. No injuries resulted. And a shipment of South American lemons was suspected of being impregnated with a “harmful biological” agent. A combined investigation by the Coast Guard, Homeland Security Department, and the FDA turned up nothing.

Nothing to fear but what we tell you to

If it seems like I’m making light of terrorist dangers, I’m not. Commissioner Crawford says that drug tampering is a source of serious concern, and it should be. But the implication that there’s a specific threat when he knows that no such threat exists, is nothing more than a tactic designed to frighten people out of shopping up north for affordable drugs. I guess the thinking is: If nobody will take our warning letters seriously, maybe terrorism fear will do the trick.

But so far the fear isn’t working. Last week, Illinois Governor Rod R. Blagojevich announced a plan that will help residents of his state purchase drugs from Britain, Ireland and Canada at savings of up to 50 percent over domestic drugs. Other states are pursuing similar plans. An associate commissioner for the FDA told the New York Times that these efforts “will raise serious concerns on the part of the FDA.”

Ooooh. “Serious” concerns. My, my, my. Sounds like someone is getting ready to fire off another one of those warning letters.

Sources:

“FDA Warns of Terrorist Drug Tampering” The Associated Press, 8/12/04, ap.org
“Illinois State Web Site to Offer Foreign Drugs” Monica Davey, The New York Times, 8/17/04, nytimes.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.